These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6994158)

  • 1. Hypothesis: prostaglandins mediate defective glucose recognition in diabetes mellitus.
    Metz SA; McRae JR; Robertson RP
    Prostaglandins Med; 1980 Apr; 4(4):247-54. PubMed ID: 6994158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sounding board. Prostaglandins, the glucoreceptor, and diabetes.
    Robertson RP; Metz SA
    N Engl J Med; 1979 Dec; 301(26):1446-7. PubMed ID: 514327
    [No Abstract]   [Full Text] [Related]  

  • 3. A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics.
    McRae JR; Metz SA; Robertson RP
    Metabolism; 1981 Nov; 30(11):1065-75. PubMed ID: 7026970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus.
    Robertson RP; Chen M
    J Clin Invest; 1977 Sep; 60(3):747-53. PubMed ID: 330566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins, glucose homeostasis, and diabetes mellitus.
    Robertson RP
    Med Clin North Am; 1981 Jul; 65(4):759-71. PubMed ID: 7024663
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prostaglandins, insulin secretion and diabetes mellitus].
    Giugliano D; Torella R; Scheen AJ; Lefebvre PJ; D'Onofrio F
    Diabete Metab; 1988 Dec; 14(6):721-7. PubMed ID: 3073092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandins, glucose homeostasis, and diabetes mellitus.
    Robertson RP
    Annu Rev Med; 1983; 34():1-12. PubMed ID: 6344749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose toxicity.
    Rossetti L; Giaccari A; DeFronzo RA
    Diabetes Care; 1990 Jun; 13(6):610-30. PubMed ID: 2192847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins and the release of insulin. A review and a proposal.
    Moran M
    Prostaglandins Leukot Essent Fatty Acids; 1988 May; 32(2):95-9. PubMed ID: 3043468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins as modulators of pancreatic islet function.
    Robertson RP
    Diabetes; 1979 Oct; 28(10):942-8. PubMed ID: 383557
    [No Abstract]   [Full Text] [Related]  

  • 12. [The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin].
    Guillemin R; Fontaine M
    C R Acad Hebd Seances Acad Sci D; 1975 May; 280(20):2353-6. PubMed ID: 807423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II diabetes, glucose "non-sense," and islet desensitization.
    Robertson RP
    Diabetes; 1989 Dec; 38(12):1501-5. PubMed ID: 2684709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
    Cryer PE; Gerich JE
    N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.
    Unger RH; Orci L
    Annu Rev Med; 1977; 28():119-30. PubMed ID: 324351
    [No Abstract]   [Full Text] [Related]  

  • 16. Defective insulin secretion in NIDDM: integral part of a multiplier hypothesis.
    Robertson RP
    J Cell Biochem; 1992 Mar; 48(3):227-33. PubMed ID: 1400609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium salicylate on hormonal responses to hypoglycaemia in type II diabetics.
    Brass EP; Halter JB; Ensinck JW; Robertson RP
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):649-55. PubMed ID: 6391745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feedback modulation of glucose-induced insulin secretion by arachidonic acid metabolites: possible molecular mechanisms and relevance to diabetes mellitus.
    Metz SA
    Prostaglandins Med; 1981 Dec; 7(6):581-9. PubMed ID: 6798594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Is diabetes mellitus a disorder of the glucoreceptor?
    Niki A; Niki H
    Lancet; 1975 Oct; 2(7936):658. PubMed ID: 52024
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of glucagon in hyperglycemia. A review (author's transl)].
    Luyckx A
    Diabete Metab; 1975 Sep; 1(3):201-8. PubMed ID: 791728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.